Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, Ro-associated Y4 pseudogene 36 (RNY4P36) is annotated as a human pseudogene derived from RNY4, a non-coding RNA of the Y RNA family. Y RNAs (including RNY4) are involved in cell functions such as DNA replication and serve as components of ribonucleoprotein complexes with Ro60 autoantigen. However, as a pseudogene, RNY4P36 does not encode a functional RNA and lacks known biological activity or therapeutic significance. No evidence exists to support RNY4P36 as a drug target, biomarker, or therapeutic receptor, and it is not implicated in any disease mechanism. Information on this pseudogene is limited to genomic annotation, with no associated molecular or clinical functionality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, Ro-associated Y4 pseudogene 36 (RNY4P36).